Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126, Pisa, Italy.
Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Neuromed, Via Atinense 18, 86077, Pozzilli, Italy.
J Neural Transm (Vienna). 2024 Apr;131(4):335-358. doi: 10.1007/s00702-024-02741-x. Epub 2024 Feb 17.
Methamphetamine (METH) produces a cytopathology, which is rather specific within catecholamine neurons both in vitro and ex vivo, in animal models and chronic METH abusers. This led some authors to postulate a sort of parallelism between METH cytopathology and cell damage in Parkinson's disease (PD). In fact, METH increases and aggregates alpha-syn proto-fibrils along with producing spreading of alpha-syn. Although alpha-syn is considered to be the major component of aggregates and inclusions developing within diseased catecholamine neurons including classic Lewy body (LB), at present, no study provided a quantitative assessment of this protein in situ, neither following METH nor in LB occurring in PD. Similarly, no study addressed the quantitative comparison between occurrence of alpha-syn and other key proteins and no investigation measured the protein compared with non-protein structure within catecholamine cytopathology. Therefore, the present study addresses these issues using an oversimplified model consisting of a catecholamine cell line where the novel approach of combined light and electron microscopy (CLEM) was used measuring the amount of alpha-syn, which is lower compared with p62 or poly-ubiquitin within pathological cell domains. The scenario provided by electron microscopy reveals unexpected findings, which are similar to those recently described in the pathology of PD featuring packing of autophagosome-like vesicles and key proteins shuttling autophagy substrates. Remarkably, small seed-like areas, densely packed with p62 molecules attached to poly-ubiquitin within wide vesicular domains occurred. The present data shed new light about quantitative morphometry of catecholamine cell damage in PD and within the addicted brain.
甲基苯丙胺(METH)在体外和体内、动物模型和慢性 METH 滥用者的儿茶酚胺神经元中产生一种细胞病理学,这在儿茶酚胺神经元中是相当特异的。这使得一些作者假设 METH 细胞病理学与帕金森病(PD)中的细胞损伤之间存在某种平行关系。事实上,METH 增加并聚集α-突触核蛋白原纤维,同时产生α-突触核蛋白的扩散。虽然α-突触核蛋白被认为是在包括经典路易体(LB)在内的患病儿茶酚胺神经元中发展的聚集物和内含物的主要成分,但目前没有研究在体内定量评估这种蛋白质,无论是在 METH 后还是在 PD 中发生的 LB 后。同样,没有研究解决α-突触核蛋白与其他关键蛋白质出现的定量比较问题,也没有研究测量与儿茶酚胺细胞病理学中非蛋白质结构相比的蛋白质。因此,本研究使用一种简化的儿茶酚胺细胞系模型来解决这些问题,该模型采用了光镜和电子显微镜(CLEM)联合的新方法,测量α-突触核蛋白的含量,其在病理细胞域中低于 p62 或多聚泛素。电子显微镜提供的场景揭示了出乎意料的发现,这些发现与最近在 PD 病理学中描述的特征相似,即自噬体样小泡的包装和关键蛋白质穿梭自噬底物。值得注意的是,在广泛的囊泡域内,出现了小的种子样区域,密集地包裹着与多聚泛素结合的 p62 分子。本数据为 PD 中儿茶酚胺细胞损伤和成瘾大脑中的定量形态计量学提供了新的视角。
J Neural Transm (Vienna). 2024-4
Acta Neuropathol Commun. 2025-2-11
J Parkinsons Dis. 2024
Cochrane Database Syst Rev. 2025-6-9
2025-1
Curr Neuropharmacol. 2024
Autophagy. 2023-5
Cell Death Dis. 2021-9-17
Arch Pharm Res. 2021-7
Hum Mol Genet. 2021-4-30